Takeda-6d
1125632-93-0
95%
2026-06-29
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName Takeda-6d Cat No CEI-1148 Description Takeda-6d showed potent inhibitory activity in both B-RAF with IC50 of 7.0nM and VEGFR2 with IC50 of 2.2nM. Abbr Takeda-6d(KDR, SNRPE) Alias CD309, FLK1, VEGFR, VEGFR2 CAS No 1125632-93-0 Molecular Weight 547.99 Purity > 95% Stability 2 years -20 centigrade Powder1 month -4 centigrade in DMSOMore than one month -80 centigrade in DMSO Storage 4 centigrade Synonyms CD309, FLK1, VEGFR, VEGFR2 Targets VEGFR2, B-RAF IC50 7.0nM, 2.2nM Molecular Formula C27H19ClFN5O3S Chemical Name 2-chloro-3-(1-cyanocyclopropyl)-N-(5-((2-(cyclopropanecarbox amido)thiazolo[5,4-b]pyridin-5-yl)oxy)-2-fluorophenyl)benzamide Solubility DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL category Specialty Chemicals(c26) cas_num 1125632-93-0 Basic Info-
Product Name:
2-Chloro-3-(1-Cyanocyclopropyl)-N-[5-({2-[(Cyclopropylcarbonyl)amino][1,3]thiazolo[5,4-B]pyridin-5-Yl}oxy)-2-Fluorophenyl]benzamide
Other Name:Takeda-6d;1125632-93-0;2-Chloro-3-(1-Cyanocyclopropyl)-N-[5-({2-[(Cyclopropylcarbonyl)amino][1,3]thiazolo[5,4-B]pyridin-5-Yl}oxy)-2-Fluorophenyl]benzamide;2-chloro-3-(1-cyanocyclopropyl)-N-(5-((2-(cyclopropanecarboxamido)thiazolo[5,4-b]pyridin-5-yl)oxy)-2-fluorophenyl)benzamide;2-Chloro-3-(1-cyanocyclopropyl)-N-[5-[[2-[(cyclopropylcarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl]oxy]-2-fluorophenyl]benzamide;2-chloro-3-(1-cyanocyclopropyl)-N-[5-[[2-(cyclopropanecarbonylamino)-[1,3]thiazolo[5,4-b]pyridin-5-yl]oxy]-2-fluorophenyl]benzamide;3vnt;4dbn;0JA;Takeda 6d;Takeda6d
CAS No.:1125632-93-0
Molecular Formula:C27H19ClFN5O3S
InChIKeys:MDPMAXSABUPRJI-UHFFFAOYSA-N
Molecular Weight:548.0
Exact Mass:547.0881165
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product